Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies

Stem Cell Research

Volumn 9, Issue 3, 2012, Pages 196-207

  Yu, Yue ^a,b   Liu, Hongling ^a,c   Ikeda, Yasuhiro ^a   Amiot, Bruce P ^d   Rinaldo, Piero ^a   Duncan, Stephen A ^e   Nyberg, Scott L ^a  

^a Mayo Clinic   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c 302 MILITARY HOSPITAL   (China)

^d Brami Biomedical Inc   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ARGINASE 1; ARGININOSUCCINATE SYNTHASE; ATP SYNTHASE 5; ATP SYNTHASE 8; CARBAMOYL PHOSPHATE SYNTHASE; CHEMOKINE RECEPTOR CXCR4; CYTOCHROME P450 2C; CYTOCHROME P450 3A; DIAZEPAM; FORKHEAD BOX A2; FORKHEAD TRANSCRIPTION FACTOR; GLUTAMATE ACETYLTRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MITOCHONDRIAL DNA; MITOCHONDRIAL SPECIFIC DNA POLYMERASE GAMMA; MITOCHONDRIAL SPECIFIC DNA POLYMERASE GAMMA 2; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOCHONDRIAL UNCOUPLING PROTEIN 2; OCTAMER TRANSCRIPTION FACTOR 4; ORNITHINE CARBAMOYLTRANSFERASE; OXYGEN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA;

CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL NUCLEUS; CELL STRUCTURE; CELL SWELLING; COPY NUMBER VARIATION; DEALKYLATION; ENZYME ACTIVITY; EX VIVO STUDY; GENE EXPRESSION; GENE REPLICATION; HUMAN; HYDROXYLATION; IN VITRO STUDY; LIVER CELL; MITOCHONDRION; NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; STEM CELL TRANSPLANTATION; UREA CYCLE;

CELL DIFFERENTIATION; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TISSUE THERAPY;

EID: 84864564708     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.06.004     Document Type: Review

References (40)

1. Armstrong L., Tilgner K., Saretzki G., Atkinson S.P., Stojkovic M., Moreno R., Przyborski S., Lako M. Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010, 28:661-673.
2. Asgari, S., Moslem, M., Bagheri-Lankarani, K., Pournasr, B., Miryounesi, M., and Baharvand, H. (in press). Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev. http://dx.doi.org/10.1007/s12015-011-9330-y.
3. Azuma H., Paulk N., Ranade A., Dorrell C., Al-Dhalimy M., Ellis E., Strom S., Kay M.A., Finegold M., Grompe M. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat. Biotechnol. 2007, 25:903-910.
4. Azuma H., Isaka Y., Nomi H., Inamoto T., Li X.K., Hounig T., Takabatake Y., Ichimaru N., Ibuki N., Matsumoto K., et al. Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be important. Transplantation 2010, 90:1328-1335.
5. Baskin-Bey E.S., Canbay A., Bronk S.F., Werneburg N., Guicciardi M.E., Nyberg S.L., Gores G.J. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G396-402.
6. Basma H., Soto-Gutierrez A., Yannam G.R., Liu L., Ito R., Yamamoto T., Ellis E., Carson S.D., Sato S., Chen Y., et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136:990-999.
7. Brown G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 1992, 284(Pt 1):1-13.
8. Cai J., Zhao Y., Liu Y., Ye F., Song Z., Qin H., Meng S., Chen Y., Zhou R., Song X., et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007, 45:1229-1239.
9. Chen C.T., Shih Y.R., Kuo T.K., Lee O.K., Wei Y.H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008, 26:960-968.
10. Chen Y.F., Tseng C.Y., Wang H.W., Kuo H.C., Yang V.W., Lee O.K. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology 2012, 55:1193-1203.
11. Cho Y.M., Kwon S., Pak Y.K., Seol H.W., Choi Y.M., Park do J., Park K.S., Lee H.K. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem. Biophys. Res. Commun. 2006, 348:1472-1478.
12. Choi S.M., Kim Y., Liu H., Chaudhari P., Ye Z., Jang Y.Y. Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 2011, 10:2423-2427.
13. Chung S., Dzeja P.P., Faustino R.S., Perez-Terzic C., Behfar A., Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S60-67.
14. DeLaForest A., Nagaoka M., Si-Tayeb K., Noto F.K., Konopka G., Battle M.A., Duncan S.A. HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 2011, 138:4143-4153.
15. Denis J., Delorme M.L., Boschat M., Nordlinger B., Opolon P. Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J. Neurochem. 1983, 40:10-19.
16. Dunn J.C., Tompkins R.G., Yarmush M.L. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 1991, 7:237-245.
17. Espejel S., Roll G.R., McLaughlin K.J., Lee A.Y., Zhang J.Y., Laird D.J., Okita K., Yamanaka S., Willenbring H. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J. Clin. Invest. 2010, 120:3120-3126.
18. Facucho-Oliveira J.M., Alderson J., Spikings E.C., Egginton S., St John J.C. Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J. Cell Sci. 2007, 120:4025-4034.
19. Garstka H.L., Schmitt W.E., Schultz J., Sogl B., Silakowski B., Perez-Martos A., Montoya J., Wiesner R.J. Import of mitochondrial transcription factor A (TFAM) into rat liver mitochondria stimulates transcription of mitochondrial DNA. Nucleic Acids Res. 2003, 31:5039-5047.
20. Haussinger D., Lamers W., Moorman A. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme 1992, 46:72-93.
21. Hickey R., Lillegard J., Fisher J., McKenzie T., Hofherr S., Finegold M., Nyberg S., Grompe M. Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology 2011, 54:1351-1359.
22. Kanki T., Ohgaki K., Gaspari M., Gustafsson C.M., Fukuoh A., Sasaki N., Hamasaki N., Kang D. Architectural role of mitochondrial transcription factor A in maintenance of human mitochondrial DNA. Mol. Cell. Biol. 2004, 24:9823-9834.
23. Koike M., Matsushita M., Taguchi K., Uchino J. Function of culturing monolayer hepatocytes by collagen gel coating and coculture with nonparenchymal cells. Artif. Organs 1996, 20:186-192.
24. Lillegard J.B., Fisher J.E., Nedredal G., Luebke-Wheeler J., Bao J., Wang W., Amoit B., Nyberg S.L. Normal atmospheric oxygen tension and the use of antioxidants improve hepatocyte spheroid viability and function. J. Cell. Physiol. 2011, 226:2987-2996.
25. Mandrioli R., Mercolini L., Raggi M.A. Benzodiazepine metabolism: an analytical perspective. Curr. Drug Metab. 2008, 9:827-844.
26. Nahmias Y., Berthiaume F., Yarmush M.L. Integration of technologies for hepatic tissue engineering. Adv. Biochem. Eng. Biotechnol. 2007, 103:309-329.
27. Parker G.C., Acsadi G., Brenner C.A. Mitochondria: determinants of stem cell fate?. Stem Cells Dev. 2009, 18:803-806.
28. Rinaldo P. Organic acids. Laboratory guide to the methods in Biochemical Genetics 2008, 137-170. Springer-Heidelberg. N. Blau, N. Duran, K. Gibson (Eds.).
29. Sancho-Bru P., Roelandt P., Narain N., Pauwelyn K., Notelaers T., Shimizu T., Ott M., Verfaillie C. Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells. J. Hepatol. 2011, 54:98-107.
30. Schieke S.M., Ma M., Cao L., McCoy J.P., Liu C., Hensel N.F., Barrett A.J., Boehm M., Finkel T. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells. J. Biol. Chem. 2008, 283:28506-28512.
31. Si-Tayeb K., Noto F.K., Nagaoka M., Li J., Battle M.A., Duris C., North P.E., Dalton S., Duncan S.A. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51:297-305.
32. Song Z., Cai J., Liu Y., Zhao D., Yong J., Duo S., Song X., Guo Y., Zhao Y., Qin H., et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009, 19:1233-1242.
33. Soto-Gutierrez A., Kobayashi N., Rivas-Carrillo J.D., Navarro-Alvarez N., Zhao D., Okitsu T., Noguchi H., Basma H., Tabata Y., Chen Y., et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat. Biotechnol. 2006, 24:1412-1419.
34. Suhr S.T., Chang E.A., Tjong J., Alcasid N., Perkins G.A., Goissis M.D., Ellisman M.H., Perez G.I., Cibelli J.B. Mitochondrial rejuvenation after induced pluripotency. PLoS One 2010, 5:e14095.
35. Takayama K., Inamura M., Kawabata K., Katayama K., Higuchi M., Tashiro K., Nonaka A., Sakurai F., Hayakawa T., Furue M.K., et al. Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol. Ther. 2012, 20:127-137.
36. Thatava T., Nelson T.J., Edukulla R., Sakuma T., Ohmine S., Tonne J.M., Yamada S., Kudva Y., Terzic A., Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011, 18:283-293.
37. Wang Y., Cui C.B., Yamauchi M., Miguez P., Roach M., Malavarca R., Costello M.J., Cardinale V., Wauthier E., Barbier C., et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011, 53:293-305.
38. Webb A.C., Smith L.D. Accumulation of mitochondrial DNA during oogenesis in Xenopus laevis. Dev. Biol. 1977, 56:219-225.
39. Ytrebo L.M., Kristiansen R.G., Maehre H., Fuskevag O.M., Kalstad T., Revhaug A., Cobos M.J., Jalan R., Rose C.F. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009, 50:165-174.
40. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.